Resvera-Flo

by North American Herb & Spice · liquid · 4 fluid ounces

  • On the market (NIH)
  • UPC 6 35824 00555 1
  • DSLD label 270115
  • Serving 1 to 2 tsp; amounts per 1 tsp
  • 24 servings

Resvera-Flo by North American Herb & Spice lists 9 ingredients, 9 with an amount per serving of 1 tsp, such as 0 g of total fat, 0 mg of cholesterol, 0 mg of sodium and 9 g of total carbohydrates. Its current label entered the NIH Dietary Supplement Label Database on February 21, 2023.

What is in Resvera-Flo?

Each row as the label prints it, per serving of 1 tsp. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Resvera-Flo: Supplement Facts rows against the market (DSLD label 270115, January 2026 release)
IngredientAmount% DVAmong products listing it
Calories 35 Calories Not reported
Calories from Fat 0 Calories Not reported
Total Fat 0 g 0%
Saturated Fat 0 g 0%
Trans Fat 0 g 0%
Cholesterol 0 mg 0%
Sodium 0 mg 0%
Total Carbohydrates 9 g 3% Carbohydrate in Resvera-Flo against 21,979 products9 g per serving; the middle half of products list 1 g to 6 g, the median 3 g.9 g

Higher than 85% of 21,979 products listing carbohydrate (median 3 g).

Dietary Fiber 0 g 0%
Sugar 7 g Not reported Sugar in Resvera-Flo against 11,807 products7 g per serving; the middle half of products list 1 g to 4 g, the median 2 g.7 g

Higher than 88% of 11,807 products listing sugar (median 2 g).

Protein 0 g 0%

Not reported: no percentage is available for that row. A missing DSLD percentage does not establish whether an FDA reference value exists.

Source: NIH ODS Dietary Supplement Label Database, label 270115 (entered February 21, 2023), version 9.4.0. See the label on DSLD or its label image (PDF). Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient.

The NIH database records one serving a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

6 products list the very same ingredients; the nearest amounts come first.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Directions: This is potent; take one or two teaspoons daily. Add to juice, water, or over yogurt.

Source: label statements in DSLD label 270115.

What else is on the label?

Other ingredients: Muscadine Concentrate, Grape Extract, Raw, Multiple Spice Oil Extract.

How many labels does Resvera-Flo have?

One label is on file, entered on February 21, 2023.

  1. Label 270115 (current) Entered February 21, 2023 · on the market · 4 fluid ounces · UPC 6 35824 00555 1

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names North American Herb & Spice (distributor), Lake Forest, IL. All North American Herb & Spice products.

Where next?